Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

NCT07653412 · clinicaltrials.gov ↗

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Obesity (Disorder)
Anti-obesity Agents
Precision Medicine

Interventions

DRUG: Semaglutide or Tirzepatide

Sponsor

National and Kapodistrian University of Athens